| Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients (NCT05638048) | Junyan Zhao | 2022-07-10 |
| Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer (NCT06561516) | Gangnam Severance Hospital | 2022-06-14 |
| Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment (NCT05426135) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-06-01 |
| Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment (NCT06653478) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-06-01 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy (NCT05427383) | Shanghai JMT-Bio Inc. | 2022-04-07 |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (NCT05494060) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-16 |
| Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer (NCT05336058) | Singlera Genomics Inc. | 2022-02-01 |
| Total Versus Partial Omentectomy in the Treatment of Gastric Cancer (NCT05238584) | University of Debrecen | 2022-01-01 |
| Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC (NCT04819971) | The First Affiliated Hospital of Zhengzhou University | 2021-12-01 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors (NCT05415475) | Chongqing Precision Biotech Co., Ltd | 2021-09-10 |
| Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type (NCT04890171) | National Cancer Center, Korea | 2021-06-11 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric Cancer (NCT04819958) | Fujian Medical University | 2021-03-31 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
| Docetaxel and Irinotecan in Gastric Cancer (NCT04770623) | Menoufia University | 2021-03-05 |
| Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer (NCT05931445) | Comprehensive Support Project for Oncology Research | 2021-01-26 |
| Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients? (NCT04797624) | Adana City Training and Research Hospital | 2021-01-15 |
| Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) (NCT04410887) | Ruijin Hospital | 2020-12-01 |
| PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (NCT04484636) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| The PLATON Network (NCT05489250) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer (NCT04486651) | Taizhou Hanzhong biomedical co. LTD | 2020-09-16 |
| Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer (NCT04526470) | Seoul National University Bundang Hospital | 2020-09-01 |
| Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy (NCT04493125) | Gangnam Severance Hospital | 2020-07-27 |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering (NCT04426669) | Intima Bioscience, Inc. | 2020-05-15 |
| Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer (NCT04135781) | Zhejiang Cancer Hospital | 2020-03-01 |
| An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (NCT03704077) | Bristol-Myers Squibb | 2019-10-31 |
| Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy (NCT04215861) | The First Affiliated Hospital of Dalian Medical University | 2019-10-01 |
| A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain (NCT04014478) | Shanghai Golden Leaf MedTec Co. Ltd | 2019-07-15 |
| The Effect of Deep Neuromuscular Block on the Perioperative Stress Response Reduction and Postoperative Recovery Enhancement in Robot-assisted Stomach Cancer Surgery (NCT03937440) | Yonsei University | 2019-07-03 |
| AZD8186 and Paclitaxel in Advanced Gastric Cancer (NCT04001569) | Seoul National University Bundang Hospital | 2019-05-14 |
| Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (NCT03644459) | Lynkcell Inc. | 2019-04-03 |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation (NCT04308837) | Icahn School of Medicine at Mount Sinai | 2018-12-03 |
| Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients (NCT03760822) | Federation Francophone de Cancerologie Digestive | 2018-11-16 |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma (NCT03488667) | University of Kansas Medical Center | 2018-06-27 |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy (NCT03515356) | University of Michigan Rogel Cancer Center | 2018-06-13 |
| Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) (NCT03448835) | The Netherlands Cancer Institute | 2018-03-07 |
| A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy (NCT03086291) | Samsung Medical Center | 2018-01-04 |
| A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (NCT03139487) | Asan Medical Center | 2017-08-07 |
| Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer (NCT03076567) | National Cancer Institute (NCI) | 2017-03-09 |
| Prospective Evaluation and Molecular Profiling in People With Gastric Tumors (NCT03027427) | National Cancer Institute (NCI) | 2017-02-01 |
| Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer (NCT03030404) | National Cancer Institute (NCI) | 2017-01-27 |
| A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach (NCT02943603) | Weijing Sun, MD, FACP | 2017-01-01 |
| The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. (NCT03384511) | Shandong Cancer Hospital and Institute | 2016-09-30 |
| Programs To Support You During Chemotherapy (NCT02489422) | Wake Forest University Health Sciences | 2016-08-01 |
| FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) (NCT02661971) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2016-06-01 |
| FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer (NCT02581462) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2016-06-01 |
| Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer (NCT02689284) | MacroGenics | 2016-01-01 |
| Effect of Modified Stylet Angulation on the Intubation With GlideScope® (NCT02547064) | Keimyung University Dongsan Medical Center | 2015-10-01 |
| The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational Study (NCT02604979) | Yonsei University | 2015-09-23 |
| A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA (NCT03057171) | Yonsei University | 2015-05-01 |
| S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy (NCT02191566) | Kangbuk Samsung Hospital | 2015-05-01 |
| Fish Oil Supplementation in Gastrointestinal Cancer (NCT02699047) | Universidade Federal de Santa Catarina | 2015-03-01 |
| Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (NCT02216149) | Heikki Joensuu | 2015-01-01 |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer (NCT02205463) | NYU Langone Health | 2014-12-01 |
| Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia (NCT02325323) | Assistance Publique - Hôpitaux de Paris | 2014-05-01 |
| Validation of MMS Test for Cancer Monitoring (NCT02113683) | MedInnovation GmbH | 2014-05-01 |
| A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach (NCT01774851) | Merrimack Pharmaceuticals | 2013-01-01 |
| Comparison of O-type Hybrid Knife and IT Knife in ESD (NCT01760070) | Xijing Hospital of Digestive Diseases | 2012-12-01 |
| Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients (NCT01618474) | Tianjin Medical University Cancer Institute and Hospital | 2012-05-01 |
| Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival (NCT02055313) | Meir Medical Center | 2012-05-01 |
| Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis (NCT01659619) | The Catholic University of Korea | 2012-04-01 |
| A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer (NCT01246960) | Eli Lilly and Company | 2011-04-01 |
| EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer (NCT02209415) | Michael Bau Mortensen | 2011-04-01 |
| Development of a Versatile Intra-operative On-screen Audiovisual Mentoring System Using TileproTM Program for Robotic Gastrectomy (NCT01319084) | Yonsei University | 2011-03-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery (NCT01179750) | Samsung Medical Center | 2010-01-01 |
| Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer (NCT01038154) | Hospital Donostia | 2009-11-01 |
| A Study With Health Educational Material on Health Promotion in Cancer Survivors (NCT00948337) | National Cancer Center, Korea | 2009-08-01 |
| Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer (NCT00911820) | Dana-Farber Cancer Institute | 2009-07-01 |
| Comparison of Standard of Care or Treatment on Protocol (NCT01010334) | New Mexico Cancer Research Alliance | 2009-03-01 |
| Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma (NCT00780494) | Stanford University | 2009-02-01 |
| A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer (NCT01257711) | National Healthcare Group, Singapore | 2008-10-09 |
| Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach (NCT00800969) | University of Zurich | 2008-10-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy (NCT00622804) | The Catholic University of Korea | 2007-07-01 |
| A Study of Vinflunine in Patients With Gastric Cancer (NCT00359476) | Bristol-Myers Squibb | 2007-03-01 |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers (NCT01445327) | National Cancer Institute (NCI) | 2007-02-20 |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer (NCT00394433) | Dana-Farber Cancer Institute | 2006-09-01 |
| Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer (NCT00446290) | Asan Medical Center | 2006-03-01 |
| Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer (NCT00857246) | NYU Langone Health | 2005-07-01 |
| Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473) | Ludwig Institute for Cancer Research | 2005-07-01 |
| Metastatic Gastric Cancer FFCD 03-07 (NCT00374036) | University Hospital, Toulouse | 2005-06-01 |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) (NCT00525785) | M.D. Anderson Cancer Center | 2004-01-01 |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer (NCT01016639) | Lund University Hospital | 2003-06-01 |
| Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer (NCT00858338) | NYU Langone Health | 2002-12-01 |
| Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma (NCT01048281) | Stanford University | 2002-08-01 |
| Trial of Adjuvant Chemotherapy for Gastric Cancer (NCT00296335) | Asan Medical Center | 2002-02-01 |
| Trial of Adjuvant Chemotherapy for Gastric Cancer (NCT00296322) | Asan Medical Center | 2001-10-01 |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer (NCT00201747) | Ohio State University Comprehensive Cancer Center | 2001-09-01 |
| Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00215514) | Dana-Farber Cancer Institute | 2000-09-01 |
| Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma (NCT00215462) | Dana-Farber Cancer Institute | 2000-06-01 |
| A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women (NCT00342004) | National Cancer Institute (NCI) | 1997-05-01 |